학술논문

KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming
Document Type
article
Source
PLOS Pathogens. 19(11)
Subject
Biological Sciences
Biomedical and Clinical Sciences
Clinical Sciences
Cancer Genomics
Human Genome
Cancer
Genetics
Emerging Infectious Diseases
Sexually Transmitted Infections
HIV/AIDS
Rare Diseases
Hematology
Infectious Diseases
2.1 Biological and endogenous factors
Generic health relevance
Inflammatory and immune system
Humans
Herpesvirus 8
Human
Interleukin-6
Nuclear Proteins
Transcription Factors
Cytokines
Herpesviridae Infections
Chromatin
Epigenesis
Genetic
Sarcoma
Kaposi
Cell Cycle Proteins
Microbiology
Immunology
Medical Microbiology
Virology
Medical microbiology
Language
Abstract
Kaposi sarcoma-associated herpesvirus (KSHV) inflammatory cytokine syndrome (KICS) is a newly described chronic inflammatory disease condition caused by KSHV infection and is characterized by high KSHV viral load and sustained elevations of serum KSHV-encoded IL-6 (vIL-6) and human IL-6 (hIL-6). KICS has significant immortality and greater risks of other complications, including malignancies. Although prolonged inflammatory vIL-6 exposure by persistent KSHV infection is expected to have key roles in subsequent disease development, the biological effects of prolonged vIL-6 exposure remain elusive. Using thiol(SH)-linked alkylation for the metabolic (SLAM) sequencing and Cleavage Under Target & Release Using Nuclease analysis (CUT&RUN), we studied the effect of prolonged vIL-6 exposure in chromatin landscape and resulting cytokine production. The studies showed that prolonged vIL-6 exposure increased Bromodomain containing 4 (BRD4) and histone H3 lysine 27 acetylation co-occupancies on chromatin, and the recruitment sites were frequently co-localized with poised RNA polymerase II with associated enzymes. Increased BRD4 recruitment on promoters was associated with increased and prolonged NF-κB p65 binding after the lipopolysaccharide stimulation. The p65 binding resulted in quicker and sustained transcription bursts from the promoters; this mechanism increased total amounts of hIL-6 and IL-10 in tissue culture. Pretreatment with the BRD4 inhibitors, OTX015 and MZ1, eliminated the enhanced inflammatory cytokine production. These findings suggest that persistent vIL-6 exposure may establish a chromatin landscape favorable for the reactivation of inflammatory responses in monocytes. This epigenetic memory may explain the greater risk of chronic inflammatory disease development in KSHV-infected individuals.